Full oral feeding attainment

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)

Only 32% of ELBW infants with gastrostomy tubes were taking full oral feeds at 18-22 month follow-up. Infants with neurodevelopmental impairment and chronic breathing problems were less likely to have

Effect: mixed; 32% (108/333)